Top entities: PROCEPT BioRobotics, Rosen Law Firm, Lawrence Rosen, Philip Kim.

What category does this event fall under?

Regulatory — classified as securities class action.

What is the sentiment of coverage?

Aggregate sentiment score: -30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated Aug 12, 2026. Coverage continues to evolve.

Regulatory securities class action

PROCEPT BioRobotics securities fraud lawsuit

Q: When did this event occur?

First reported Aug 10, 2026; last updated Aug 12, 2026.

Q: What is the market impact?

General. The lawsuit could negatively impact PROCEPT's stock price and investor confidence, as it alleges accounting irregularities and inflated sales figures.

Analysis based on 6 articles · First reported Aug 10, 2026 · Last updated Aug 12, 2026

Sentiment

-30

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The lawsuit could negatively impact PROCEPT's stock price and investor confidence, as it alleges accounting irregularities and inflated sales figures. The company may face legal costs, potential settlements, and increased regulatory scrutiny, which could affect its financial performance and market valuation.

Medical Devices

Event Summary

Rosen Law Firm has filed a securities class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of purchasers of its common stock between February 28, 2024 and February 25, 2026. The lawsuit alleges that PROCEPT made materially false and misleading statements and failed to disclose that it used an extensive discount program to incentivize bulk orders exceeding procedure demand, artificially inflating reported U.S. handpiece unit sales and revenues. This allegedly created a glut of field inventory, with over 10,000 excess units by the end of the Class Period, and left PROCEPT unable to achieve its 2025 handpiece sales and revenue guidance. Investors who purchased during the Class Period may be entitled to compensation, and the lead plaintiff deadline is September 22, 2026.

Key Actions

100 Rosen Law Firm filed class action PROCEPT BioRobotics

Entities Involved

stock

PROCEPT BioRobotics

PROCEPT is the defendant in the securities fraud lawsuit, accused of using undisclosed discount programs to inflate sales. The allegations could lead to financial penalties, reputational damage, and a decline in stock price.

Importance 100.0 Sentiment -40.0

priv

Rosen Law Firm

Rosen Law Firm filed the class action lawsuit and is seeking lead plaintiff. The firm stands to gain legal fees if the case is successful, enhancing its reputation in securities litigation.

Importance 80.0 Sentiment 20.0

per

Lawrence Rosen

Lawrence Rosen is a founding partner of Rosen Law Firm and is involved in the case, representing the firm's interests and potentially benefiting from a successful outcome.

Importance 30.0 Sentiment 10.0

per

Philip Kim

Philip Kim is an attorney at Rosen Law Firm handling the case, providing legal representation and potentially gaining professional recognition from the litigation.

Importance 30.0 Sentiment 10.0

Relationships

PROCEPT BioRobotics related ↔ Rosen Law Firm

PROCEPT BioRobotics related ↔ Lawrence Rosen

PROCEPT BioRobotics related ↔ Philip Kim

Rosen Law Firm related ↔ Lawrence Rosen

Rosen Law Firm related ↔ Philip Kim

Lawrence Rosen managing partner ↔ Philip Kim Lawrence Rosen is the founder and managing partner of Rosen Law Firm, where Philip Kim is a partner, and they actively c

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard